Tuberculous pericarditis and HIV infection

Where antiretroviral drugs are available, interaction of protease inhibitors and rifampicin must be considered and guidelines for this have been issued by the Centers for Disease Control and Prevention. 14 Coexistence of epidemic tuberculosis and HIV infection, interested clinicians, and good basic laboratory services in Zimbabwe and South Africa provide an appropriate environment for further work on TB pericarditis and adjunctive prednisolone. [...]the resurgence of all types of tuberculosis should alert general physicians and cardiologists in the developed world to the possibility of TB pericarditis.